- $1.29bn
- $1.14bn
- $441.84m
- 66
- 83
- 70
- 85
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 287 | 283 | 271 | 323 | 319 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 277 | 244 | 286 | 319 | 317 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 134 | 128 | 157 | 162 | 154 |
Provision for Income Taxes | |||||
Net Income After Taxes | 103 | 100 | 123 | 128 | 123 |
Net Income Before Extraordinary Items | |||||
Net Income | 103 | 100 | 123 | 128 | 123 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 103 | 100 | 123 | 128 | 123 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.32 | 2.07 | 2.58 | 2.35 | 2.27 |
Dividends per Share |